Pharmacological and nutraceutical treatments for borderline personality disorder
-
Published:2024-08
Issue:
Volume:
Page:
-
ISSN:0013-7006
-
Container-title:L'Encéphale
-
language:en
-
Short-container-title:L'Encéphale
Author:
Gérolymos Cyril,
Boyer Laurent,
Masson Marc,
Fond GuillaumeORCID
Reference27 articles.
1. Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies;Leichsenring;World Psychiatry,2024
2. Efficacy and tolerability of asenapine compared with olanzapine in borderline personality disorder: an open-label randomized controlled trial;Bozzatello;CNS Drugs,2017
3. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine;Cowdry;Arch Gen Psychiatry,1988
4. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study;Zanarini;Am J Psychiatry,2003
5. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: the World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce;Sarris;World J Biol Psychiatry,2022